AKBA
Akebia Therapeutics, Inc. · Healthcare
SVP and Chief Medical Officer Steven Keith Burke sold $41K of Akebia Therapeutics, Inc.
Sold$40,842
$1.68Price
24,311Shares
−3%Stake
What AKBA did after the filing
- The stock from Fri, Feb 2 close, $1.65
- +14.5%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Mar 18 close.
Traded Thu, Feb 1. Filed Fri, Feb 2, 11:10 AM ET, during the session. Returns use the Feb 2 close and the Mar 18 close. Not investment advice.